Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6425
    -0.0000 (-0.01%)
     
  • OIL

    83.54
    +0.81 (+0.98%)
     
  • GOLD

    2,410.60
    +12.60 (+0.53%)
     
  • Bitcoin AUD

    100,782.32
    +3,026.59 (+3.10%)
     
  • CMC Crypto 200

    1,380.51
    +67.89 (+5.17%)
     
  • AUD/EUR

    0.6028
    -0.0003 (-0.05%)
     
  • AUD/NZD

    1.0900
    +0.0026 (+0.24%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,171.20
    -223.11 (-1.28%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    38,060.21
    +284.83 (+0.75%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

At €18.44, Is It Time To Put Bureau Veritas SA (EPA:BVI) On Your Watch List?

Bureau Veritas SA (EPA:BVI), which is in the professional services business, and is based in France, saw a decent share price growth in the teens level on the ENXTPA over the last few months. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy? Let’s take a look at Bureau Veritas’s outlook and value based on the most recent financial data to see if the opportunity still exists.

Check out our latest analysis for Bureau Veritas

What's the opportunity in Bureau Veritas?

Good news, investors! Bureau Veritas is still a bargain right now. My valuation model shows that the intrinsic value for the stock is €28.04, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. However, given that Bureau Veritas’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from Bureau Veritas?

ENXTPA:BVI Past and Future Earnings May 14th 2020
ENXTPA:BVI Past and Future Earnings May 14th 2020

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Though in the case of Bureau Veritas, it is expected to deliver a relatively unexciting earnings growth of 8.7%, which doesn’t help build up its investment thesis. Growth doesn’t appear to be a main reason for a buy decision for the company, at least in the near term.

What this means for you:

Are you a shareholder? Even though growth is relatively muted, since BVI is currently undervalued, it may be a great time to increase your holdings in the stock. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on BVI for a while, now might be the time to enter the stock. Its future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy BVI. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Bureau Veritas. You can find everything you need to know about Bureau Veritas in the latest infographic research report. If you are no longer interested in Bureau Veritas, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.